November 18, 2026 at 10:30 PM

After-Hours Movers: INHD, ACTU, GMM Lead the Small-Cap Scan

INHD led a group of 10 active small-cap stocks flagged for editorial review.

After-hours movers roundup

Inno Holdings Inc. (INHD) led the latest after-hours scan, gaining approximately 67.4%. The table below ranks the leading qualifying movers captured in the latest snapshot.

Top 10 After-Hours Movers

Scanner snapshot captured 2026-11-18T22:30:03.019Z.

#TickerCompanyMovePriceVolumeMarket Cap
1INHDInno Holdings Inc.+67.4%$3.852,538,630$5.8M
2ACTUActuate Therapeutics, Inc.+23.9%$0.304216,320,525$14.8M
3GMMGlobal Mofy AI Limited+9.4%$1.70761,917$15.1M
4ALLOAllogene Therapeutics, Inc.+8.0%$0.75181,452,812$241.1M
5INMBINmune Bio Inc.+7.8%$1.11114,225$31.9M
6BDMDBaird Medical Investment Holdings Ltd+7.5%$0.0850667,219$2.5M
7IEIvanhoe Electric Inc.+7.0%$6.40346,327$954.6M
8FLNAFilana Therapeutics, Inc.+6.3%$0.5795199,777$27.4M
9ZBAOZhibao Technology Inc.+6.2%$0.1426142,925$1.2M
10OFRMOnce Upon a Farm, PBC+6.2%$12.08130,750$480.8M

What’s Driving the Moves

INHD — Inno Holdings Inc.

INHD gained approximately 67.4% in the scanner snapshot. A possible catalyst was Inno Holdings Inc. Announces Resumption of Trading on Nasdaq. The headline should be verified against the original source before publication.

ACTU — Actuate Therapeutics, Inc.

ACTU gained approximately 23.9% in the scanner snapshot. A possible catalyst was Actuate Therapeutics Reports Positive Monotherapy Data in Aggressive Melanoma Preclinical Model with Daily Dosing of Elraglusib Oral Tablet at ENA 2026. The headline should be verified against the original source before publication.

GMM — Global Mofy AI Limited

GMM gained approximately 9.4% in the scanner snapshot. A possible catalyst was Global Mofy Announces Indirect Investment in Anthropic as Part of AI Expansion Strategy. The headline should be verified against the original source before publication.

ALLO — Allogene Therapeutics, Inc.

ALLO gained approximately 8.0% in the scanner snapshot. A possible catalyst was Allogene Therapeutics Reports First Clinical Data from Phase 1 RESOLUTION Study of ALLO-329 in Autoimmune Disease. The headline should be verified against the original source before publication.

INMB — INmune Bio Inc.

INMB gained approximately 7.8% in the scanner snapshot. A possible catalyst was INmune Bio (INMB) Q3 2026 Earnings Call Transcript. The headline should be verified against the original source before publication.

BDMD — Baird Medical Investment Holdings Ltd

BDMD gained approximately 7.5% in the scanner snapshot. A possible catalyst was Baird Medical Enters South Korea Market through Strategic Distribution Partnership with ALLIS MED. The headline should be verified against the original source before publication.

IE — Ivanhoe Electric Inc.

IE gained approximately 7.0% in the scanner snapshot. A possible catalyst was Ivanhoe Electric (IE) Misses Estimates, Is It Still 75% Below Fair Value?. The headline should be verified against the original source before publication.

FLNA — Filana Therapeutics, Inc.

FLNA gained approximately 6.3% in the scanner snapshot. A possible catalyst was Filana Therapeutics Names Biopharma Executive Jill M. Quigley to Board. The headline should be verified against the original source before publication.

ZBAO — Zhibao Technology Inc.

ZBAO gained approximately 6.2% in the scanner snapshot. A possible catalyst was Zhibao Technology Reports 16% Revenue Growth to RMB 319.9 Million and Narrows Annual Net Loss by 95.3%. The headline should be verified against the original source before publication.

OFRM — Once Upon a Farm, PBC

OFRM gained approximately 6.2% in the scanner snapshot. A possible catalyst was Popular organic toddler snack recall could cost celebrity-backed food brand $30 million. The headline should be verified against the original source before publication.

What To Watch Next

Premarket and after-hours moves can reverse quickly. Editors should verify the catalyst, filing history, financing activity, float structure and liquidity before publication.